Response to "Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias"

Affiliations

• ¹ Vall d'Hebron Institute of Oncology, Barcelona, Spain; The Institute of Cancer Research, London, United Kingdom; SOLTI Breast Cancer Research Group, Barcelona, Spain.
• ² Vall d'Hebron Institute of Oncology, Barcelona, Spain; Medical Oncology Department, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medical Oncology and Hematology Department, Princess Margaret Cancer Centre, Toronto, Canada.
• ³ Vall d'Hebron Institute of Oncology, Barcelona, Spain.
• ⁴ Vall d'Hebron Institute of Oncology, Barcelona, Spain; Medical Oncology Department, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain.
• ⁵ Medical Oncology Department, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain.
• ⁶ Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: [email protected].